Shanxi C&Y Pharmaceutical Group Co., Ltd.

39
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000016D0
CNY
13.97
-0.28 (-1.96%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Operating Income
861.00
838.00
790.00
820.00
917.00
836.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
861.00
838.00
790.00
820.00
917.00
836.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
21.00
17.00
33.00
46.00
49.00
55.00
General and Administration Expenses
398.00
411.00
423.00
503.00
566.00
657.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
757.00
770.00
755.00
835.00
931.00
1,020.00
Operating Profit (PBDIT) excl Other Income
103.00
67.00
35.00
-15.00
-14.00
-184.00
Other Income
26.00
38.00
44.00
33.00
35.00
31.00
Operating Profit (PBDIT)
189.00
160.00
131.00
73.00
72.00
-102.00
Interest
21.00
17.00
33.00
46.00
49.00
55.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
61.00
59.00
59.00
65.00
64.00
65.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
87.00
79.00
34.00
-86.00
-73.00
-297.00
Provision for Tax
34.00
5.00
6.00
7.00
9.00
-17.00
Profit After Tax
24.00
42.00
25.00
-118.00
-91.00
-262.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
0.10
0.17
0.10
-0.50
-0.40
-1.23
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 2.77% vs 6.02% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 54.12% vs 89.82% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 27.17% vs -48.61% in Dec 2024

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2025 is -41.10% vs 67.45% in Dec 2024

Compare Profit and Loss Results of Shanxi C&Y Pharmaceutical Group Co., Ltd.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
No of Months
12
12
Operating Income
861.00
0
861.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
861.00
0
861.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0
0.00
0%
Raw Materials Consumed
0.00
0
0.00
0%
Power & Fuel Cost
0.00
0
0.00
0%
Employee Cost
0.00
0
0.00
0%
Operating Expenses
21.00
0
21.00
0%
General and Administration Expenses
398.00
0
398.00
0%
Selling and Distribution Expenses
0.00
0
0.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
0.00
0
0.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
757.00
0
757.00
0%
Operating Profit (PBDIT) excl Other Income
103.00
0.00
103.00
0%
Other Income
26.00
0
26.00
0%
Operating Profit (PBDIT)
189.00
0
189.00
0%
Interest
21.00
0
21.00
0%
Profit before Depriciation and Tax
0.00
0
0.00
0%
Depreciation
61.00
0
61.00
0%
Profit Before Taxation & Exceptional Items
0.00
0
0.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
87.00
0
87.00
0%
Provision for Tax
34.00
0
34.00
0%
Profit After Tax
24.00
0
24.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
0.00
0
0.00
0%
Profit Available for appropriations
0.00
0
0.00
0%
Appropriations
0.00
0
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
0.1015
0
0.10
0%
Profit And Loss - Net Sales
Net Sales 861.18 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 2.77% vs 6.02% in Dec 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 103.40 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 54.12% vs 89.82% in Dec 2024

Profit And Loss - Interest
Interest 21.76 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 27.17% vs -48.61% in Dec 2024

Profit And Loss - Profit After Tax
Profit After Tax 24.85 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -41.10% vs 67.45% in Dec 2024